Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diabetinol is a consumer health company that develops and markets dietary supplements specifically formulated for blood sugar management. The company's flagship product, Diabetinol, contains a blend of natural ingredients such as cinnamon, chromium, and bitter melon, which are intended to support healthy insulin function and glucose metabolism. Unlike traditional biotechnology firms, Diabetinol focuses on the nutraceutical market, providing non-prescription options for individuals managing metabolic health. The company operates primarily through e-commerce and direct-to-consumer sales channels. Its products are positioned as supportive therapies for maintaining glycemic control in conjunction with diet and exercise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diabetinol.